berberine has been researched along with Electrocardiogram QT Prolonged in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Due to drug-drug interactions caused by the inhibition or induction of cytochrome P450 enzymes, changes in drug metabolism are the major causes of drug toxicity, CYP3A4 is one of the key isozymes, and involved in the metabolism of over 60% of clinical drugs." | 1.48 | The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins. ( Fang, L; Fang, Q; Feng, P; Guo, F; Li, B; Liang, Z; Xu, X; Zhan, G; Zhang, B; Zhao, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, P | 1 |
| Zhao, L | 1 |
| Guo, F | 1 |
| Zhang, B | 1 |
| Fang, L | 1 |
| Zhan, G | 1 |
| Xu, X | 1 |
| Fang, Q | 1 |
| Liang, Z | 1 |
| Li, B | 1 |
| Dai, DZ | 1 |
1 review available for berberine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy.
Topics: Animals; Anti-Arrhythmia Agents; Berberine; Cardiomegaly; Humans; Ion Channels; Long QT Syndrome; My | 2000 |
1 other study available for berberine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
Topics: Action Potentials; Animals; Atorvastatin; Berberine; Cytochrome P-450 CYP3A; ERG1 Potassium Channel; | 2018 |